Used primarily in the treatment of major depressive disorder (MDD), this compound functions as a multimodal antidepressant. It enhances serotonergic activity in the brain by modulating multiple serotonin receptors—acting as an agonist at 5-HT1A receptors and antagonist at 5-HT3, 5-HT7, and sometimes 5-HT1D receptors—while also inhibiting the serotonin transporter (SERT). This unique mechanism contributes to improved mood and cognitive function in patients with depression. It is particularly noted for having fewer sexual side effects compared to other antidepressants and may improve cognitive symptoms such as poor concentration and memory issues associated with depression. The compound is taken orally and is designed for daily use in adults, with effects typically observed within a few weeks of consistent treatment.